Skip to search formSkip to main contentSkip to account menu

neoantigens

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
T cell cancer neoantigens are created from peptides derived from cancer-specific aberrant proteins, such as mutated and fusion… 
2020
2020
Antigens and adjuvants were fused into “traceless” nanogels in order to produce an enhanced personalized cancer vaccine. 
Highly Cited
2019
Highly Cited
2019
Neoantigens (nAgs) are promising tumor antigens for cancer vaccination with the potential of inducing robust and selective T cell… 
2019
2019
BackgroundDNA vaccines against cancer held great promises due to the generation of a specific and long-lasting immune response… 
2018
2018
Comprehensive genomic and transcriptomic analysis demonstrate that tumor-infiltrating T lymphocytes that react to mutated… 
Highly Cited
2000
Highly Cited
2000
Dendritic cells (DCs) have the unique ability to initiate an immune response in vivo by capturing antigens (Ags) in peripheral… 
Highly Cited
1999
Highly Cited
1999
For many years, visions for development of successful immunotherapy of cancer revolved around the induction of immune responses… 
Review
1993
Review
1993
Alcohol abuse is a major cause of liver disease. While ethanol itself has been shown to be hepatotoxic, its primary metabolite… 
Highly Cited
1974
Highly Cited
1974
Lymph‐node cells from rats bearing tumours apparently lacking in tumour rejection antigens were cytotoxic in vitro for cultured…